Newsletter | January 30, 2025

01.30.25 -- Upgrading The Vial/Vein-To-Vein Process With Enterprise-Level Digital Infrastructure

SPONSOR

Introducing a new way to source solutions for improving, refining, and optimizing your CGT manufacturing! From April 8-10, Life Science Connect brings you the next virtual showcase from its network of trusted communities: Cell & Gene Therapy Tech Expo. Simply bring your attention, questions, and manufacturing requirements (no travel, cost, or inconvenience!) and experience this unique opportunity to learn about the latest technologies in CGT manufacturing and how they can help solve your biggest challenges.

FOCUS ON MANUFACTURING

Upgrading The Vial/Vein-To-Vein Process With Enterprise-Level Digital Infrastructure

The cell and gene therapy's value chain has come to be known as the vein-to-vein/vial-to-vein process. Enterprise-level digital infrastructure can address the sector's challenges in a variety of ways.

Genomic Medicine Demands Manufacturing Innovation

The promise of novel therapeutic modalities can only be realized when effective science is paired with efficient manufacturing to provide cost-effective therapies to patients in need.

Gene Therapies: A Guide To Aseptic Single-Use Connectors

It's important to frequently evaluate your manufacturing process, gauging if improvements can be made. Learn how aseptic connections can impact your efficiency and speed as you continue to scale-up.

Simplifying EV/Exosome Research & Development

Modern solutions are continuing to be developed to help those working in biologics overcome historic Exosomes / Extracellular Vesicles challenges.

How To Successfully Scale QC For Rapid Growth

Learn how one CDMO successfully streamlined and modernized its QC workflows and processes to address challenges related to the increasing demand for cell and gene therapy manufacturing services.

Real-Time Monitoring Of Key Bioprocess Parameters

The success of this experiment shows how the integration of Process Analytical Technology probes into bioreactors can enhance process understanding and enable precise bioprocess monitoring and control.

5 Overlooked Challenges In Viral Vector Manufacturing

Here we explore the use of viral vectors in gene therapies, as well as factors that negatively affect them during manufacturing.

Importance Of Data Reproducibility For Developing Safe Gene Therapies

What are viral-based vectors and why are reproducible quantitation of gene expression important in gene therapy? Explore these questions as well as the interplay among gene therapy vector components.

Manifolding For Scale-Up, Safety, And Speed

The use of manifolds to fill bags for bioprocessing or advanced therapies contributes to time savings, improved process quality, and optimal use of cleanroom and personnel resources.

MANUFACTURING SOLUTIONS

Innovative Solutions For mRNA Vaccine Manufacturing - Polyplus

Support Growth With Material For Cell Culture - Eppendorf SE

Biopharmaceutical Services - Cytiva

Evaluating Performance Factors Of Cryopreserved PBMCs - Lonza

Thermal Ramping Characterization Solution: Aurora TX - RedShiftBio

Connect With Cell & Gene: